Breathing problems after Capromorelin (Entyce) in dogs

128 reports to the FDA describe breathing problems in dogs given Capromorelin. That is 8.4% of all reports for this medicine, compared with 2.7% across reports for all dog medicines, so it is reported unusually often with this medicine.

128Reports

77%Marked serious

18%Recovered

45%Died or euthanised

2 daysTypical onset

How soon it started

Same day

40 36%

1–2 days

17 15%

3–7 days

11 9.8%

1–4 weeks

17 15%

Over a month

27 24%

How the animals did

Recovered

22 17%

Recovered with lasting effects

1 0.8%

Still unwell when reported

27 21%

Died

30 23%

Euthanised

28 22%

Not known

20 16%

Problems reported at the same time

58 45%

57 45%

47 37%

35 27%

34 27%

33 26%

25 20%

23 18%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause breathing problems in dogs?: 128 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 2 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Breathing problems with similar medicines

Breathing problems after Maropitant (Cerenia) 1,103 reports · 9.3% of its reports
Breathing problems after Mirtazapine (Mirataz) 48 reports · 17% of its reports

All reported side effects of Capromorelin in dogs · Medicines most reported with breathing problems